Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 13, 2020

SELL
$30.88 - $37.94 $252,104 - $309,742
-8,164 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$18.95 - $35.43 $154,707 - $289,250
8,164 New
8,164 $289,000
Q1 2020

May 15, 2020

SELL
$13.94 - $28.25 $265,389 - $537,823
-19,038 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$19.24 - $28.41 $220,105 - $325,010
-11,440 Reduced 37.54%
19,038 $411,000
Q3 2019

Nov 13, 2019

BUY
$20.03 - $40.08 $320,940 - $642,201
16,023 Added 110.85%
30,478 $689,000
Q2 2019

Aug 14, 2019

BUY
$25.78 - $39.77 $372,649 - $574,875
14,455 New
14,455 $520,000

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.24B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Diametric Capital, LP Portfolio

Follow Diametric Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Diametric Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Diametric Capital, LP with notifications on news.